These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 29359389

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The diagnostic utility of microRNA 222-3p, microRNA 21-5p, and microRNA 122-5p for HCV-related hepatocellular carcinoma and its relation to direct-acting antiviral therapy.
    Khairy A, Ibrahim MK, AbdElrahman M, Fouad R, Zayed N, Ayman Y, Abdellatef Z, Yosry A.
    Arab J Gastroenterol; 2022 May; 23(2):108-114. PubMed ID: 35606305
    [Abstract] [Full Text] [Related]

  • 5. Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells.
    Devhare PB, Sasaki R, Shrivastava S, Di Bisceglie AM, Ray R, Ray RB.
    J Virol; 2017 Mar 15; 91(6):. PubMed ID: 28077652
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Rituximab May Cause Increased Hepatitis C Virus Viremia in Rheumatoid Arthritis Patients Through Declining Exosomal MicroRNA-155.
    Liao TL, Hsieh SL, Chen YM, Chen HH, Liu HJ, Lee HC, Chen DY.
    Arthritis Rheumatol; 2018 Aug 15; 70(8):1209-1219. PubMed ID: 29575671
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma exosome microRNAs are indicative of breast cancer.
    Hannafon BN, Trigoso YD, Calloway CL, Zhao YD, Lum DH, Welm AL, Zhao ZJ, Blick KE, Dooley WC, Ding WQ.
    Breast Cancer Res; 2016 Sep 08; 18(1):90. PubMed ID: 27608715
    [Abstract] [Full Text] [Related]

  • 11. Increased peripheral CD4+ regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C.
    Langhans B, Nischalke HD, Krämer B, Hausen A, Dold L, van Heteren P, Hüneburg R, Nattermann J, Strassburg CP, Spengler U.
    J Hepatol; 2017 May 08; 66(5):888-896. PubMed ID: 28040549
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
    Zhang S, Ouyang X, Jiang X, Gu D, Lin Y, Kong SK, Xie W.
    Int J Med Sci; 2015 May 08; 12(7):590-8. PubMed ID: 26283876
    [Abstract] [Full Text] [Related]

  • 14. Circulating microRNAs as a biomarker to predict therapy efficacy in hepatitis C patients with different genotypes.
    Fan Z, Zhang Q, Chen H, He P, Li Y, Si M, Jiao X.
    Microb Pathog; 2017 Nov 08; 112():320-326. PubMed ID: 28993299
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Efficient Suppression of Hepatitis C Virus Replication by Combination Treatment with miR-122 Antagonism and Direct-acting Antivirals in Cell Culture Systems.
    Liu F, Shimakami T, Murai K, Shirasaki T, Funaki M, Honda M, Murakami S, Yi M, Tang H, Kaneko S.
    Sci Rep; 2016 Aug 03; 6():30939. PubMed ID: 27484655
    [Abstract] [Full Text] [Related]

  • 17. Hepatitis C Virus-Induced Exosomal MicroRNAs and Toll-Like Receptor 7 Polymorphism Regulate B-Cell Activating Factor.
    Liao TL, Chen YM, Hsieh SL, Tang KT, Chen DY, Yang YY, Liu HJ, Yang SS.
    mBio; 2021 Dec 21; 12(6):e0276421. PubMed ID: 34724826
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.